Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MUC16, CA125, CA-125 AND Prognosis
56 results:

  • 1. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
    Tan Y; Liu R; Xue JW; Feng Z
    Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
    Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
    J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
    Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
    J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
    Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
    Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
    Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer.
    Tejerina-Miranda S; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Reviejo AJ; Pedrero M; Pingarrón JM; Barderas R; Campuzano S
    Int J Biol Macromol; 2023 Sep; 248():125996. PubMed ID: 37499706
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
    Rong W; Shao S; Pu Y; Ji Q; Zhu H
    Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. D-dimer to lymphocyte ratio can serve as a potential predictive and prognostic value in colorectal cancer patients with liver metastases.
    Lu S; Gong S; Wu F; Ma L; Xiang B; Li L; Tang W
    BMC Surg; 2023 Mar; 23(1):64. PubMed ID: 36966285
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
    Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
    BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
    Ain QU; Muhammad S; Hai Y; Peiling L
    J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of Prognostic Factors of Rectal cancer and Construction of a Prognostic Prediction Model Based on Bayesian Network.
    Li R; Zhang C; Du K; Dan H; Ding R; Cai Z; Duan L; Xie Z; Zheng G; Wu H; Ren G; Dou X; Feng F; Zheng J
    Front Public Health; 2022; 10():842970. PubMed ID: 35784233
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The association of clinicopathological characterizations of colorectal cancer with membrane-bound mucins genes and LncRNAs.
    Iranmanesh H; Entezari M; Rejali L; Nazemalhosseini-Mojarad E; Maghsoudloo M; Aghdaei HA; Zali MR; Hushmandi K; Rabiee N; Makvandi P; Ashrafizadeh M; Hashemi M
    Pathol Res Pract; 2022 May; 233():153883. PubMed ID: 35452967
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Trajectories of Perioperative Serum Tumor Markers and colorectal cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.
    Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
    EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for colorectal cancer.
    Xie J; Huang Z; Jiang P; Wu R; Jiang H; Luo C; Hong H; Yin H
    Front Immunol; 2021; 12():760747. PubMed ID: 34659267
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular Pathways Associated with Kallikrein 6 Overexpression in colorectal cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mucin 16 Promotes colorectal cancer Development and Progression Through Activation of Janus Kinase 2.
    Liu Z; Gu Y; Li X; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Yang W; Huang Q
    Dig Dis Sci; 2022 Jun; 67(6):2195-2208. PubMed ID: 33982216
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
    Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
    Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with colorectal Tumors.
    Zhu X; Yi K; Hou D; Huang H; Jiang X; Shi X; Xing C
    Med Sci Monit; 2020 Jul; 26():e923828. PubMed ID: 32753569
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.